Pethidine, an opioid of predominant kappa agonism 1 , is a phenylpiperidine derivative and has a chemical structure resembling local anaesthetics. Hence, pethidine possesses membrane stabilizing properties 2, 3 and has been used as the sole intrathecal anaesthetic agent for surgery. It also offers postoperative analgesia with relatively few side-effects 4, 5 . Intrathecal pethidine has reportedly been able to produce limited motor blockade, potentially rendering earlier postoperative mobility 6 .
We attempted to evaluate the efficacy and safety of intrathecal pethidine, chiefly in terms of the incidence of hypotension associated with its use compared with intrathecal bupivacaine in patients that had been scheduled for transurethral resection of prostate (TURP).
MATERIALS AND METHODS
This randomized double-blind study, approved by the Hospital Ethics Committee, comprised 40 male patients (aged 65-80 years) of ASA physical status 1 and 2 presenting for TURP for benign prostatic hypertrophy under spinal (subarachnoid) anaesthesia.
The exclusion criteria included: 1. patient refusal, 2. presence of a psychiatric history, 3 . skin infection at the site of lumbar puncture or the presence of systemic infection, 4. presence of a progressive neurologic disease, 5. presence of a bleeding dyscrasia, 6. presence of any major organ failure, 7. body weight of less than 40 kg or more than 70 kg, 8. body height of less than 150 cm or more than 185 cm. After written consent, the patients were randomized (by sealed envelope assignment) into two groups; group A (control group) and group B (study group).
The patients were fasted as required for general 
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anaesthesia. No premedication was given but all patients were reassured and the anaesthetic procedure was explained the day before the operation. Intravenous access was established in all patients in the operating room with baseline mean arterial blood pressure (non-invasively) and heart rate obtained. Each of the patients received an intravenous preloading with 500 ml of Gelofundin (B. Braun Melsungen AG, Penang, Malaysia: succinylated gelatin, Na 142 mmol/l, Ca 1.4 mmol/l, Cl 80 mmol/l) (MW 3500) over 20 minutes and they also received 40% oxygen by mask throughout the anaesthetic.
Every patient received a subarachnoid block in the left lateral position at the L2-3 or L3-4 level via a 22g Quincke needle.
Each patient in group A received 2 ml of 0.5% plain bupivacaine intrathecally while group B received 2 ml of 2.0% pethidine in normal saline intrathecally.
The anaesthetic agents were injected over 20 seconds in each case, with the bevels of the needles facing upwards. The patients were then turned to the supine position for the minute before the following assessment.
Assessment
During the first 30 minutes after spinal anaesthesia, the patients were assessed as follows. Noninvasive blood pressure, heart rate (continuous lead II ECG) and respiration rate were recorded each minute.
Patients were also evaluated every two minutes as to the highest sensory level of block to pin prick, the time taken to reach it and the maximum degree of motor blockade on the modified Bromage scale 7 .
Each patient was assessed regarding shivering, itch, nausea, vomiting and sedation at every five-minute interval. In this study, sedation was defined by a Ramsay score 8 of four, i.e. the patient was asleep but had a brisk response to a light glabellar tap or loud auditory stimulus. In this scoring system, there are six levels of sedation; three with the patient awake and three with the patient asleep. The awake levels are: 1, patient anxious and agitated or restless or both; 2, patient co-operative, orientated and tranquil; 3, patient responding to commands only. Asleep levels were dependent on the patient's response to a light glabellar tap or loud auditory stimulus: level 4, a brisk response; 5, a sluggish response; and 6, no response.
Any reduction of the mean arterial blood pressure of more than 20% of the baseline was promptly treated with 3 mg IV boluses of ephedrine. The presence of respiratory depression (i.e: shallow respiration at the rate of eight per minute or slower) would have provided justification to abandon the study and to administer intravenous naloxone.
After surgery, the patients were sent to the highdependency area and assessments were done at the following times: (a) Every ten minutes on the time taken from the highest level of dermatomal block (to pin prick) to regress to the first lumbar dermatome (L1). (b) Every hour on the time taken for the first request for analgesia postoperatively as well as the degree of sedation, respiratory depression, pruritus, nausea and vomiting during the first 24 hours after anaesthesia.
Statistics
For comparison of the patient demographic data, the Student's t test was used.
Baseline values of mean arterial blood pressure and heart rate were compared using the Wilcoxon rank sum test.
The incidence of hypotension (defined here as a reduction of the mean arterial blood pressure by 20% or greater) was compared between the two groups with χ 2 -test. The number of subjects in each group was determined to detect, with a power of 0.8 and a P value of less than 0.05, a difference of 40% reduction in the incidence of hypotension between the two groups in comparison with their respective baseline values.
The Wilcoxon rank sum test was used for the assessment of changes in heart rate, the duration of surgery, the highest sensory dermatomal block (and the time taken to reach it as well as the time taken for it to regress to L1 dermatomal block), the degree of motor block and the time taken to the first request for analgesia between the two groups.
Fisher's exact test was used to assess the significance of the incidence of pruritus, shivering, sedation, nausea and vomiting between the two groups. No significant difference between the two groups was found.
RESULTS
Both group A and group B were similar in terms of weight, height and age ( Table 2) .
No significant difference was detected in their baseline values of mean arterial blood pressure and heart rate (Table 2 ). There was no difference in the incidence of hypotension between the two groups after spinal anaesthesia (Table 3) .
However, after spinal anaesthesia, there was a significant difference in heart rate, with a significantly greater number of patients in group B registering a lower heart rate than patients in group A (P<0.05) ( Table 4 ).
The highest dermatomal sensory block and the time taken to achieve it were similar in both groups. The time taken for the sensory block to regress to the first lumbar dermatome was also the same for both the groups ( Table 5 ). The time taken from the administration of anaesthesia to the first request for analgesia postoperatively was shorter for the pethidine group (P<0.05). The pethidine group also experienced a lower degree of motor blockade (P<0.05).
In terms of side-effects, the pethidine group had a higher incidence of sedation as well as nausea and vomiting (P<0.05) ( Table 6 ).
None of the patients required general anaesthesia, even though the recommended 10th thoracic dermatomal block (T 10 ) was not achieved in some patients.
DISCUSSION
In this study, we were chiefly concerned with the incidence of hypotension, defined here as a reduction of the mean arterial pressure of 20% or more from the baseline value during spinal anaesthesia caused by either technique 4 . There have been mixed reports of spinal pethidine producing a slower rate of onset as well as a lesser degree of hypotension 4, 6 .
Unlike previous authors 4 , we argued whether the calculation of the dose of pethidine based on body weight alone at the expense of varying the volume of (11) No significant difference between the two groups was detected. MAP denotes mean arterial pressure and hypotension is defined as a MAP reduction of 20% or greater in comparison with the baseline value.
No significant difference between the two groups was detected.
TABLE 5
The highest sensory level of thoracic (T) dermatomal block to pin prick, median (range) and time to reach it, mean (SD), time taken for the block to regress from HSB to 1st lumbar dermatome, mean (SD). The maximum degree of motor block by Bromage score (median range), the duration of surgery, mean (SD) and the time taken from anaesthesia to the first request for analgesia, mean (SD).
Group A Group B
Highest Sensory Block (HSB) T10 (T7-T11) T10.5 (T7-T12) Time to HSB (minutes) 10 the drug administered intrathecally was relevant when the body height could have been another variable. Therefore, in this study we opted to keep the concentration and volume of pethidine constant in our cohort of patients weighing between 41 and 70 kg to study the variation of the "average" patient's response to a standard dose of intrathecal pethidine. We fixed the dose of pethidine at 40 mg as we found in our pilot study that the larger dose of 100 mg of pethidine proposed by another investigator previously 6 was almost invariably associated with a considerable degree of hypotension and bradycardia. The suspicion that these haemodynamic swings were dose-dependent was borne out by the demonstrably less severe changes observed with 40 mg of pethidine.
Although we deliberately did not use as great a dose as the commonly employed 1 mg/kg body weight in other studies 4,5,9 , we did not find the incidence of hypotension to be lower in the intrathecal pethidine group in comparison with a similar cohort of patients, which apart from receiving our usual dose of 2 ml of 0.5% bupivacaine, had indistinguishable treatment in terms of fasting, prehydration as well as the conduct of the spinal anaesthesia itself. However, we do not suggest a further reduction of the dosage of pethidine as the sensory block may then not be adequate for this surgery as with our current dosage, the recommended tenth thoracic dermatomal block was not reached in some patients.
Even with our current dose of pethidine 40 mg intrathecally (about 0.66 mg/kg -1 body weight of pethidine intrathecally), we had two patients who had bradycardia (heart rates of 42 beats/min and 40 beats/min respectively) that we believed could not be explained by the degree of sympathetic block alone. The possibility of this being an effect mediated by central opioid receptors acting through the vagus could not be excluded 10 . In both the cases, bradycardia was successfully reversed by atropine.
In both the groups of patients in our study, adequate anaesthesia was provided. However, in the case of intrathecal pethidine, previous studies had demonstrated a shorter duration of spinal anaesthetic action 5, 6 . In our study, the first request for analgesia came earlier after anaesthesia and surgery in the spinal pethidine group, despite its postulated prolonged anti-nociceptive effect in the dorsal horn of the spinal cord as distinct from the axonal blockade produced by local anaesthetics 11 . As in a previous study by Sangailankarn et al 6 , we found that in our patients the maximum cephalad spread of dermatomal block as well as the time taken to achieve it were similar between the pethidine and the local anaesthetic groups. The incomplete motor blockade induced by spinal pethidine did not appear to hinder surgery.
There was a higher incidence of nausea and vomiting in the spinal pethidine group. Although previous studies had suggested that this was related to the height of the block, this was not clearly demonstrable by our study 6, 10, 12 . Hence we believe a central opioid effect to be at least partially responsible for this finding. The same explanation could be offered for the higher incidence of drowsiness in the intrathecal pethidine group and this was in keeping with results from previous studies 6, 4 . We did not find the incidence of shivering with pethidine reduced, contrary to a previous report 13 .
Spinal pethidine had been used successfully for a variety of operations with what appeared to be readily treatable side-effects. There have been reports of early respiratory depression even though late respiratory depression had not been documented 14, 15 . None of our patients had respiratory depression at any stage.
CONCLUSION
Intrathecal pethidine appears to be an alternative to local anaesthetic agents for TURP. We did not find intrathecal pethidine superior in terms of the reduction of the incidence of hypotension. Apart from this, patients who had received spinal pethidine had a higher incidence of sedation, nausea and vomiting as well as an apparently shorter duration of postoperative analgesia. We consider that intrathecal pethidine does not offer any advantage to intrathecal bupivacaine for TURP.
